SCOTT SCHLACKMAN - 25 Jun 2025 Form 4 Insider Report for MEDIFAST INC (MED)

Role: Director
Signature: /s/ Jason L. Groves, attorney-in-fact
Issuer symbol: MED
Transactions as of: 25 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 26 Jun 2025, 19:05:00 UTC
Previous filing: 24 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SCHLACKMAN SCOTT	Director	C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE	/s/ Jason L. Groves, attorney-in-fact	26 Jun 2025	0001645617

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MED	Common Stock	Award	$0	+11,168	+78%	$0.000000	25,549	25 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.

Content

These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.